This is the first investigation using CrossFit training as a mode of exercise as well as in combination with ASX supplementation on SEMA3C, apelin, chemerin, omentin1, visfatin, resistin, adiponectin, leptin, vaspin, and RBP4 in males with obesity. The gene discussed is APLN; the disease is obesity due to melanocortin 4 receptor deficiency.